Anvisa aprova o Lenacapavir, medicamento injetável para prevenção do HIV

from Saúde em Foco - Luis Fernando Correia · host CBN

Luis Fernando Correia fala sobre a Anvisa aprovar o uso do Lenacapavir, para prevenir o HIV. 'Estamos falando de uma injeção aplicada apenas duas vezes por ano que oferece proteção contínua contra o HIV. Um intervalo de seis meses entre as doses. Algo inédito', destaca o comentarista. Ouça. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Jan 13, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Anvisa aprova o Lenacapavir, medicamento injetável para prevenção do HIV

0:00 4:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Saúde em Foco - Luis Fernando Correia?

This episode is 4 minutes long.

When was this Saúde em Foco - Luis Fernando Correia episode published?

This episode was published on January 13, 2026.

Can I download this Saúde em Foco - Luis Fernando Correia episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!